Revolution Medicines Inc. (RVMD): Price and Financial Metrics
RVMD Price/Volume Stats
| Current price | $44.06 | 52-week high | $62.40 |
| Prev. close | $43.29 | 52-week low | $25.91 |
| Day low | $42.53 | Volume | 2,673,600 |
| Day high | $44.22 | Avg. volume | 1,401,604 |
| 50-day MA | $51.69 | Dividend yield | N/A |
| 200-day MA | $42.91 | Market Cap | 7.41B |
RVMD Stock Price Chart Interactive Chart >
Revolution Medicines Inc. (RVMD) Company Bio
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
RVMD Price Returns
| 1-mo | -22.40% |
| 3-mo | -2.99% |
| 6-mo | 14.44% |
| 1-year | 61.45% |
| 3-year | 63.55% |
| 5-year | N/A |
| YTD | 53.63% |
| 2023 | 20.40% |
| 2022 | -5.36% |
| 2021 | -36.42% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...